The Role of Interleukins in Colorectal Cancer
2020 · International Journal of Biological Sciences · 140 citations
https://doi.org/10.7150/ijbs.46651
J
Jingjing Li
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
293
Papers
5.7K
Citations
38
h-index
108
i10-index
Jingjing Li is an academic researcher from Weifang Medical University. The author has contributed to research in topics: RNA modifications and cancer & Ovarian cancer diagnosis and treatment & RNA Research and Splicing. The author has an h-index of 38, co-authored 250 publications.
ORCID: 0000-0001-8000-7410Papers by this author
worksHistotype-specific copy-number alterations in ovarian cancer
2012 · BMC Medical Genomics · 60 citations
https://doi.org/10.1186/1755-8794-5-47
<scp>GSTZ</scp> 1‐1 Deficiency Activates <scp>NRF</scp> 2/ <scp>IGF</scp> 1R Axis in <scp>HCC</scp> via Accumulation of Oncometabolite Succinylacetone
2019 · The EMBO Journal · 53 citations
https://doi.org/10.15252/embj.2019101964
A Myristoylated Alanine-Rich C Kinase Substrate–Related Peptide Suppresses Cytokine mRNA and Protein Expression in LPS-Activated Canine Neutrophils
2012 · American Journal of Respiratory Cell and Molecular Biology · 35 citations
https://doi.org/10.1165/rcmb.2012-0278oc
Neutrophils Regulate Humoral Autoimmunity by Restricting Interferon-γ Production via the Generation of Reactive Oxygen Species
2015 · Cell Reports · 29 citations
https://doi.org/10.1016/j.celrep.2015.07.021
Twenty years of Gendicine® rAd-p53 cancer gene therapy: The first-in-class human cancer gene therapy in the era of personalized oncology
2023 · Genes & Diseases · 25 citations
https://doi.org/10.1016/j.gendis.2023.101155
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat